CLINICAL_TRIALS
trial_result
· 2025-05-28
Clinical Trial Update: An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism [Phase 2]
Summary
Phase 2 open-label, multiple-dose study of RZ358 in congenital hyperinsulinism has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rezolute | Conditions: Congenital Hyperinsulinism | Phase 2 | Status: COMPLETED | Results posted: 2025-05-28